Merck conundrum, page-72

  1. 2,800 Posts.
    lightbulb Created with Sketch. 400
    Some research carried out by myself,

    Sequential Meetings:
    It's common to have a Type C meeting early in development to address initial questions and then transition to Type B meetings as the product progresses toward specific milestones. For example, a sponsor might have a Type C meeting to discuss an initial concept for a new drug, then have a Type B meeting (e.g., pre-IND) to discuss clinical trial design after the initial concept is further developed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
25.0¢
Change
0.005(2.04%)
Mkt cap ! $365.0M
Open High Low Value Volume
25.0¢ 25.3¢ 24.5¢ $620.5K 2.512M

Buyers (Bids)

No. Vol. Price($)
6 66277 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 22044 3
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.